SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer (NSCLC). A UK Randomized Phase III Trial

被引：0
|
作者：
Ngai, Yenting [1 ]
Hanna, Gerard [2 ]
Conibear, John [3 ]
Counsell, Nicholas [1 ]
Hughes, Laura [1 ]
Farrelly, Laura [1 ]
Landau, David [4 ]
机构：
[1] Cr Uk & UCL Canc Trials Ctr, London, England
[2] Belfast City Hosp, Belfast, Antrim, North Ireland
[3] St Bartholomews Hosp, London, England
[4] Guys & St Thomas NHS Fdn Trust, Oncol, London, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Stereotactic ablative radiotherapy (SABR); Stereotactic radiosurgery (SRS); Oligometastatic; non-small cell lung cancer (NSCLC);
D O I：
10.1016/j.jtho.2016.11.2185
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.06-003
引用
收藏
页码：S1425 / S1426
页数：2
相关论文
共 50 条
  • [1] SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC). A UK randomised phase III trial
    Landau, D. B.
    Hughes, L.
    Ngai, Y.
    Hanna, G. G.
    Conibear, J.
    Farrelly, L.
    Counsell, N.
    LUNG CANCER, 2017, 103 : S54 - S54
  • [2] SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC): a randomised phase III trial
    McDonald, F.
    Mak, K. M.
    Teague, J.
    Landau, D.
    Hanna, G.
    Farrelly, L.
    Counsell, N.
    LUNG CANCER, 2020, 139 : S91 - S91
  • [3] SARON: stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer (NSCLC)
    Mak, Ka-Man
    McDonald, Fiona
    Teague, Jonathan
    Faivre-Finn, Corinne
    Forster, Martin
    Hanna, Gerard
    Moinuddin, Syed
    Conibear, John
    Harden, Susan
    Popat, Sanjay
    Califano, Raffaele
    Farrelly, Laura
    Counsell, Nicholas
    Saron, T. M. G.
    LUNG CANCER, 2022, 165 : S71 - S71
  • [4] Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 21 - 24
  • [5] Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer
    Conibear, John
    Chia, Brendan
    Ngai, Yenting
    Bates, Andrew Tom
    Counsell, Nicholas
    Patel, Rushil
    Eaton, David
    Faivre-Finn, Corinne
    Fenwick, John
    Forster, Martin
    Hanna, Gerard G.
    Harden, Susan
    Mayles, Philip
    Moinuddin, Syed
    Landau, David
    BMJ OPEN, 2018, 8 (04):
  • [6] Oligometastatic non-small cell lung cancer: a narrative review of stereotactic ablative radiotherapy
    Dohopolski, Michael
    Iyengar, Puneeth
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (05) : 5944 - 5953
  • [7] Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer
    Ricardi, Umberto
    Levra, Niccolo Giaj
    Badellino, Serena
    Alongi, Filippo
    JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2235 - 2237
  • [8] Local ablative radiotherapy for oligometastatic non-small cell lung cancer
    Suh, Yang-Gun
    Cho, Jaeho
    RADIATION ONCOLOGY JOURNAL, 2019, 37 (03): : 149 - 155
  • [9] CyberKnife stereotactic ablative radiotherapy (SABR) in patients with non-small cell lung cancer ( NSCLC)
    Leschenko, Y.
    Chebotareva, T.
    Spizhenko, N.
    Fedusenko, A.
    Sharaevskiy, O.
    Buryk, V.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S39 - S39
  • [10] Utility of stereotactic ablative radiotherapy/stereotactic body radiation therapy in the setting of oligometastatic non-small cell lung cancer
    Song, Andrew
    Lu, Bo
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 657 - 660
12345